HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Davis, D. Articles by Lachmann, P. J. Search for Related Content PubMed PubMed Citation Articles by Davis, D. Articles by Lachmann, P. J. Agricola Articles by Davis, D. Articles by Lachmann, P. J.

Antisera raised against the second variable region of the external envelope glycoprotein of human immunodeficiency virus type 1 cross-neutralize and show an increased neutralization index when they act together with antisera to the V3 neutralization epitope

¹ Molecular Immunopathology Unit, MRC Centre, Hills Road, Cambridge CB2 2QH
and² Department of Genito-Urinary Medicine, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2QQ, U.K.

Antibodies have been raised against a synthetic peptide (IRDKIQKENALFRNL) containing a neutralizing epitope within the second variable region of the human immunodeficiency virus type 1 (HIV-1) SF2 strain external envelope glycoprotein (gp120) and also against equivalent peptides of the HIV-1 LAI, RF and MN isolates. The resulting antisera cross-react with heterologous peptides but binding to heterologous recombinant gp120 is more restricted. Antisera to HIV-1 SF2, RF and MN are able to neutralize homologous virus. Some cross-neutralization is also observed, but a consensus peptide failed to induce neutralizing antibodies to any of the isolates studied. Antibodies to the V2 and V3 epitopes give a higher neutralization index when acting together than when the individual sera are used alone. Antibodies induced in natural infection bind to two sets of hexamers within the region encompassed by the 15-mer peptide, and the response to these can differ between infected individuals and within the same host over time.

Received 7 April 1993; accepted 27 July 1993.

This article has been cited by other articles:

				J. L. Martinez-Torrecuadrada, J. P. M. Langeveld, R. H. Meloen, and J. I. Casal Definition of neutralizing sites on African horse sickness virus serotype 4 VP2 at the level of peptides J. Gen. Virol., October 1, 2001; 82(10): 2415 - 2424. [Abstract] [Full Text] [PDF]